September 7, 2010 – New analyses of subgroups from the SORT OUT III study provide detail on longer-term follow-up safety and efficacy outcomes in diabetics and patients with acute coronary syndrome and multiple lesions.Three new analyses of subgroups were presented at the European Society of Cardiology (ESC) meeting last week in Stockholm.
